What one share of Rocket One holds
We are a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. We are focused on developing (i) a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); (ii) a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT);
Rocket One’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.81 |
|---|---|
| Cash and investments | $0.34 |
| Book value | $0.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$12.40 | — | — | — | $0.76 |
| 2019 | — | −$21.02 | — | — | — | $5.92 |
| 2020 | — | −$14.56 | — | — | — | $8.64 |
| 2021 | — | −$16.02 | — | — | — | $10.30 |
| 2022 | — | −$9.50 | — | — | — | $4.69 |
| 2023 | — | −$2.38 | — | — | — | $2.19 |
| 2024 | — | −$1.28 | — | — | — | $0.86 |
| 2025 | — | −$0.90 | — | — | — | $0.40 |
Common questions about Rocket One
How much does one share of Rocket One earn?
Over the last 12 months, Rocket One lost $0.81 for each share.
Does Rocket One pay a dividend?
Rocket One didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Rocket One’s book value per share?
Rocket One’s book value is $0.35 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Rocket One have?
Each share of Rocket One has $0.34 of cash and investments, as of June 30, 2026.
Has Rocket One bought back shares?
Rocket One’s share count rose about 6760% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.